| Market Size in 2025 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 29.6 Billion | USD 282.7 Billion | 28.5% | 2025 |
FrequentlyAsked Questions
AI in synthetic biology means using machine learning, deep learning, generative AI, and other computational methods to create, study, and improve biological systems. AI can analyze large amounts of genetic, molecular, and biological data to find patterns and predict how genes, proteins, cells, and biological processes will behave.
The key growth drivers for the AI in synthetic biology market include the increasing adoption of AI for biological design and optimization, growing demand for faster drug discovery and development, rising investment in biotechnology and AI research, increasing availability of genomic and biological datasets, and the expansion of automated laboratories.
The major challenges restraining the growth of the AI in synthetic biology market include high infrastructure and computational costs, limited availability and quality of biological data, lack of explainability and reliability of AI models, regulatory uncertainty, data privacy and intellectual-property concerns, and biosecurity risks. AI models require large, standardized, high-quality datasets, while biological data remain fragmented across different sources, limiting model performance.
Based on the application, the drug discovery and development segment is expected to dominate the AI in synthetic biology market growth during the projected period.
Key emerging trends include the rapid adoption of generative AI and protein language models, which are enabling de novo protein design, protein optimization, and prediction of molecular structures and functions with greater speed and precision.
According to the report, the global AI in synthetic biology market size was worth around USD 29.6 billion in 2025 and is predicted to grow to around USD 282.7 billion by 2034.
The global AI in synthetic biology market is expected to grow at a CAGR of 28.5% during the forecast period.
The global AI in synthetic biology industry growth is expected to be led by North America over the forecast period.
The global AI in synthetic biology market is dominated by players like IBM Corporation, Arzeda, Google DeepMind, Microsoft Corporation, Benevolent AI, Synthace, Insilico Medicine, Zymergen, Ginkgo Bioworks, Recursion Pharmaceuticals, Berkeley Lights, Twist Bioscience, Atomwise, XtalPi, and AbCellera, among others.
The AI in synthetic biology market report covers the geographical market along with a comprehensive competitive landscape analysis. It also includes cash flow analysis, profit ratio analysis, market basket analysis, market attractiveness analysis, sentiment analysis, PESTLE analysis, trend analysis, SWOT analysis, trade area analysis, demand & supply analysis, Porter’s five forces analysis, and value chain analysis.
HappyClients